Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Immediate Amyloid-beta perturbations and interactors in Alzheimer's disease

FY 2013-14

Summary
Alzheimer’s disease is quickly becoming a major health concern for the aging population of Canada. Though much is known about the disease, there are still many questions regarding the molecular mechanisms by which Alzheimer’s disease progresses. My project is designed to close these persistent knowledge gaps in our understanding of the most central molecular interactions underlying Alzheimer’s disease. The deposition of a small protein fragment, referred to as amyloid-beta or 'Abeta', outside of brain cells is a well-recognized early event in Alzheimer's disease. A popular model posits that exposure of cells to Abeta initiates a toxic cascade of molecular interactions. The precise molecular players and mechanism underlying toxicity is not known, but our preliminary data suggest that more than one toxic pathway exists. The possibility to study this hypothesis emerged recently when we obtained a first-in-Canada machine for studying the molecular interactions within cells or tissues. We will use this tool to define earliest brain changes in response to Abeta that may serve as markers for the early diagnosis of Alzheimer’s disease. We will also uncover Abeta docking sites on brain cells to derive rational disease intervention strategies. In combination, early diagnosis and new intervention strategies will greatly improve the prognosis for individuals affected by Alzheimer’s disease. I chose to undertake graduate studies at the University of Toronto in the laboratory of Dr. Gerold Schmitt-Ulms as I believe the projects have the ability to advance the field, as well as provide me with excellent training and opportunities to advance toward my career goals. The location in downtown Toronto and the affiliation the University of Toronto has with other nearby, world-class research institutions can allow for great collaborations and provide a great deal of resources. The Schmitt-Ulms laboratory also has some of the most advanced equipment currently available, which will allow for ground-breaking studies to be performed. Once completing my Master’s degree I hope to further my education by completing a doctoral program and then pursue a career in medical research, with a focus on neurodegenerative diseases. I believe that having access to and gaining expertise with the most advanced technologies available, as well as the ability to collaborate with some of the brightest minds in the field will make me well prepared and propel me towards these future aspirations.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
311863
Name
Brethour Dylan E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Immediate Amyloid-beta perturbations and interactors in Alzheimer's disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Amyloid-Beta Peptides; Disease Mechanism; Early Diagnosis And Intervention; Mass Spectrometry; Protein Interactions
Abstract
Alzheimer’s disease is quickly becoming a major health concern for the aging population of Canada. Though much is known about the disease, there are still many questions regarding the molecular mechanisms by which Alzheimer’s disease progresses. My project is designed to close these persistent knowledge gaps in our understanding of the most central molecular interactions underlying Alzheimer’s disease. The deposition of a small protein fragment, referred to as amyloid-beta or 'Abeta', outside of brain cells is a well-recognized early event in Alzheimer's disease. A popular model posits that exposure of cells to Abeta initiates a toxic cascade of molecular interactions. The precise molecular players and mechanism underlying toxicity is not known, but our preliminary data suggest that more than one toxic pathway exists. The possibility to study this hypothesis emerged recently when we obtained a first-in-Canada machine for studying the molecular interactions within cells or tissues. We will use this tool to define earliest brain changes in response to Abeta that may serve as markers for the early diagnosis of Alzheimer’s disease. We will also uncover Abeta docking sites on brain cells to derive rational disease intervention strategies. In combination, early diagnosis and new intervention strategies will greatly improve the prognosis for individuals affected by Alzheimer’s disease. I chose to undertake graduate studies at the University of Toronto in the laboratory of Dr. Gerold Schmitt-Ulms as I believe the projects have the ability to advance the field, as well as provide me with excellent training and opportunities to advance toward my career goals. The location in downtown Toronto and the affiliation the University of Toronto has with other nearby, world-class research institutions can allow for great collaborations and provide a great deal of resources. The Schmitt-Ulms laboratory also has some of the most advanced equipment currently available, which will allow for ground-breaking studies to be performed. Once completing my Master’s degree I hope to further my education by completing a doctoral program and then pursue a career in medical research, with a focus on neurodegenerative diseases. I believe that having access to and gaining expertise with the most advanced technologies available, as well as the ability to collaborate with some of the brightest minds in the field will make me well prepared and propel me towards these future aspirations.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Brethour, Dylan E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~